日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inflammatory memory disables a DDR1 degradation checkpoint to enable pancreatic cancer growth

炎症性记忆会禁用DDR1内存退化检查点,从而促进胰腺癌的生长。

Yang, Fei; Lin, Bo; Yuan, Zihang; Yuan, Yongkang; Pu, Xiaohong; Wang, Chunlan; Watari, Kosuke; Luo, Rongkui; Sun, Beicheng; Karin, Michael; Su, Hua

USP38 functions as an oncoprotein by downregulating the p53 pathway through deubiquitination and stabilization of MDM2

USP38 通过去泛素化和稳定 MDM2 来下调 p53 通路,从而发挥癌蛋白的作用。

Zhao, Shanyu; Liu, Xiaoli; Luo, Rongkui; Jian, Zitao; Xu, Chen; Hou, Yingyong; Liu, Xiuping; Zhang, Pingzhao

Author Correction: Proteogenomic insights into the biology and treatment of pan-melanoma

作者更正:蛋白质基因组学对泛黑色素瘤生物学和治疗的见解

Xiang, Hang; Luo, Rongkui; Wang, Yunzhi; Yang, Bing; Xu, Sha; Huang, Wen; Tang, Shaoshuai; Fang, Rundong; Chen, Lingli; Zhu, Na; Yu, Zixiang; Akesu, Sujie; Wei, Chuanyuan; Xu, Chen; Zhou, Yuhong; Gu, Jianying; Zhao, Jianyuan; Hou, Yingyong; Ding, Chen

SYT4 Interacts with PSMC6 to Facilitate Malignant Progression in Gastric Carcinoma via Activating Wnt/β-catenin Signaling

SYT4与PSMC6相互作用,通过激活Wnt/β-catenin信号通路促进胃癌恶性进展

Huang, Wen; Luo, Rongkui; Wang, Huimei; Yang, Shuo; Yu, Zixiang; Liu, Yufeng; Liang, Huaiyu; Shen, Yanyan; Zhang, Xiaolei; Shen, Licheng; Akesu, Sujie; Xu, Chen; Hou, Yingyong

Immune and Histopathological Biomarkers for Prognosis and Neoadjuvant Immunotherapy Response in Intrahepatic Cholangiocarcinoma

肝内胆管癌预后及新辅助免疫治疗反应的免疫和组织病理学生物标志物

Nasir, N Jannah M; Chew, Edwin J C; Zhu, Kai; Wu, Gaohua; Luo, Rongkui; Leow, Wei Qiang; Lim, Tony K H; Gao, Qiang; Shi, Ruoyu; Chew, Valerie; Zhou, Jian

TRPV4 drives the progression of leiomyosarcoma by promoting ECM1 generation and co-activating the FAK/PI3K/AKT/GSK3β pathway.

TRPV4 通过促进 ECM1 生成和共同激活 FAK/PI3K/AKT/GSK3β 通路来驱动平滑肌肉瘤的进展

Zhou Qiwen, You Yang, Zhao Yingying, Xiao Shuxiu, Song Zhengqing, Huang Chuxin, Qian Jiali, Lu Weiqi, Tong Hanxing, Zhang Yong, Wang Zhiming, Li Wei, Zhang Chenlu, Guo Xi, Luo Rongkui, Hou Yingyong, Cui Jiefeng, Lu Lili, Zhou Yuhong

CPZ: A Highly Sensitive Diagnostic Biomarker for the Differentiation Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma, Particularly in Poorly Differentiated Hepatocellular Carcinoma

CPZ:一种用于鉴别肝细胞癌和肝内胆管癌(尤其适用于低分化肝细胞癌)的高灵敏度诊断生物标志物

Deng, Minying; Luo, Rongkui; Chen, Lingli; Wang, Huimei; Huang, Wen; Song, Qi; Jiang, Dongxian; Xu, Lei; Su, Jieakesu; Xu, Chen; Hou, Yingyong

Histopathologic Grading of Residual Tumor Predicts Survival of Intrahepatic Cholangiocarcinoma Patients Treated With Neoadjuvant Therapy: Major Pathologic Response and Its Clinical Significance

残余肿瘤的组织病理学分级可预测接受新辅助治疗的肝内胆管癌患者的生存期:主要病理反应及其临床意义

Wu, Gaohua; Chen, Xiufen; Luo, Rongkui; Koh, Ye Xin; Lim, Tony Kiat Hon; Chew, Valerie; Zhou, Jian; Fan, Jia; Gao, Qiang; Zhu, Kai; Shi, Ruoyu

Three-dimensional turbo-spin-echo amide proton transfer-weighted and intravoxel incoherent motion imaging mri for triple-negative breast cancer: a comparison with molecular subtypes and histological grades

三维快速自旋回波酰胺质子转移加权和体素内不相干运动成像磁共振成像在三阴性乳腺癌中的应用:与分子亚型和组织学分级的比较

Zhang, Nan; Shao, Xiali; Xu, Lianyan; Zhu, Wei; Wang, Haiyu; Luo, Rongkui; Yang, Chun; Ye, Xiaodan; Zeng, Mengsu; Chen, Caizhong; Yue, Xiuzheng; Bi, Zhenghong; Lu, Xin

A Real-World Study of Resectable NSCLC Following Neoadjuvant Immunotherapy: Should Postoperative Adjuvant Immunotherapy be Recommended?

新辅助免疫治疗后可切除非小细胞肺癌的真实世界研究:术后是否应推荐辅助免疫治疗?

Li, Ming; Yin, Hao; Jin, Yue; Keshava, Hari B; Luo, Rongkui; Feng, Mingxiang; Sun, Fenghao